Gapping down
In reaction to earnings/guidance:
- GBT -30.8%, EPZM -22.9%, NEWR -14%, PS -13.3%, AZPN -9.8% (also provides update on 10-K and 10-Q filing), OTRK -9.8%, MTD -9.1%, CYRX -8.9%, AYX -8.8%, NVRO -8.3%, ELAN -7.9%, RDFN -7.8%, PETQ -7.7%, SAIL -7.6%, EA -7.5%, TNDM -7.2%, STMP -6.8%, CDAY -6.6%, FLS -6.1%, WSC -5.7%, PBYI -5.5%, PTON -5.5%, PLNT -5.4%, EXEL -5.2%, CZR -5.1%, DBX -4.9%, GH -4.6%, NLOK -4.4%, ANGI -4.1%, BLDP -4%, GLPG -3.8%, PK -3.7%, BHF -3.6%, XPO -3.5%, LYV -3.4%, EBS -3.1%, TWNK -3%, AAN -3%, WYNN -2.9%, VLDR -2.9%, BILL -2.7%, BMRN -2.7%, RRGB -2.7%, EPAY -2.5%, IOVA -2.4%, AES -2.2%, HRC -2.2%, LMNX -2.1%, MCHP -2% (also names new CEO and increases dividend), BFAM -2%, VSAT -1.9% (also names new CEO), SHO -1.9%, UBER -1.6%, FGEN -1.6%, ACLS -1.5%, NVTA -1.5%, BKNG -1.4%, TDC -1.3%, PRDO -1.3%, SWX -1.3%, MAIN -1.1%, GRPN -0.9%
Other news:
- ASMB -50.9% (says Phase 2 study of vebicorvir has not achieved meaningful sustained virologic response rates)
- MRAM -12.3% (files $100 mln mixed securities shelf offering)
- AFMD -9.3% (AFMD and Artiva Bio enter into collaboration agreement)
- PBYI -5.5% (announces interim results from Phase II SUMMIT trial)
- CCL -3.2% (announced the temporary suspension (from Nov 7 to Dec 26) of Costa Deliziosa cruises to Greece)
- CVBF -2.4% (announces stock repurchase plan)
- TTCF -1.9% (stock offering)
- FBC -1.9% (prices offering of 9,112,705 shares of the Company's common stock at $30.60 per share)
- TWLO -1.8% (stock offering)
- BLDR -1.6% (acquires Kansas City Building Supply)
- UFPI -1.2% (affiliate announces equity investment in Italy)
Analyst comments:
- BGNE -3.3% (downgraded to Underweight from Neutral at Piper Sandler)
- AMSC -3% (downgraded to Hold from Buy at Canaccord Genuity)
- MLM -1.2% (downgraded to Hold from Buy at Jefferies)